SEC Filing Summary: Healthcare Acquisition Corp. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Healthcare Acquisition Corp. on July 23, 2007, reporting events as of July 19, 2007. The registrant is a Delaware corporation headquartered in Des Moines, Iowa. The filing serves as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
Note: The input metadata references "Altimmune, Inc.", but the filing text explicitly identifies the registrant as "Healthcare Acquisition Corp." This summary reflects the content of the provided filing text.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification rather than a financial statement.
Material Changes and Events
- Item 8.01 (Other Events): The Company issued a press release on July 19, 2007, regarding a special meeting of stockholders scheduled for July 27, 2007.
- Acquisition Approval: The purpose of the meeting is to approve the previously announced acquisition of PharmAthene, Inc.
- Exhibit 99.1: The press release dated July 19, 2007, is attached as an exhibit to this filing.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, or a discussion of risks and contingencies. The document strictly notifies stockholders of the upcoming vote on the PharmAthene, Inc. acquisition.
Key Facts for Investor Verification
- Verify the outcome of the special stockholder meeting held on July 27, 2007, regarding the acquisition of PharmAthene, Inc.
- Review the attached press release (Exhibit 99.1) for specific terms of the acquisition not detailed in this summary.
- Confirm the post-transaction corporate structure and ticker symbol changes, as this filing precedes the finalization of the deal.